论文部分内容阅读
目的探讨铝碳酸镁混悬剂联合胃炎Ⅰ号方治疗慢性萎缩性胃炎的临床疗效。方法选取祁阳县人民医院2015年1月—2016年1月收治的慢性萎缩性胃炎患者120例,随机分为对照组和观察组,各60例。患者入院后均给予三联疗法,对照组患者给予铝碳酸镁混悬剂治疗,观察组患者在对照组基础上给予胃炎Ⅰ号方治疗,两组患者均持续治疗2周。比较两组患者的临床疗效,治疗前后临床症状积分。结果观察组患者临床疗效优于对照组(P<0.05)。治疗前,两组患者胃痛、纳差、嗳气、痞满积分比较,差异无统计学意义(P>0.05);治疗后,观察组患者胃痛、纳差、嗳气、痞满积分低于对照组(P<0.05)。结论铝碳酸镁混悬剂联合胃炎Ⅰ号方治疗慢性萎缩性胃炎临床疗效确切,可有效缓解患者临床症状。
Objective To investigate the clinical curative effect of aluminum magnesium carbonate suspension combined with gastritis Ⅰ prescription on chronic atrophic gastritis. Methods 120 patients with chronic atrophic gastritis who were treated in Qiyang County People’s Hospital from January 2015 to January 2016 were randomly divided into control group and observation group, with 60 cases each. All patients were given triple therapy after admission. Patients in the control group were treated with aluminum magnesium carbonate suspension. Patients in the observation group were treated with gastritis I on the basis of the control group, and both groups were treated for 2 weeks. The clinical efficacy of the two groups were compared and the clinical symptom score was calculated before and after treatment. Results The clinical efficacy of the observation group was better than that of the control group (P <0.05). Before treatment, there was no significant difference between the two groups in the scores of stomachache, anorexia, belching and pimples (P> 0.05). After treatment, the scores of stomachache, anorexia, belching and fullness in the observation group were lower than those in the control group P <0.05). Conclusion The combination of hydrotalcite suspension and gastritis I formula in the treatment of chronic atrophic gastritis is effective and can effectively relieve the clinical symptoms.